These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 33273019)

  • 1. Role of cardiophrenic lymph node removal in advanced ovarian cancer.
    Boria F; Chiva L
    Int J Gynecol Cancer; 2021 Feb; 31(2):307. PubMed ID: 33273019
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiophrenic lymph nodes in advanced ovarian cancer.
    Agusti N; Bonaldo G; Kahn RM; Rosati A; Nachira D; Pan TL; Mburu A; Kochiashvili G; Paredes P; Hsu HC; Davies-Oliveira J; Ramirez PT
    Int J Gynecol Cancer; 2024 Jan; 34(1):150-158. PubMed ID: 38097346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary debulking surgery for advanced epithelial ovarian cancer with isolated enlarged para-aortic lymph node by robotic transumbilical single port approach.
    Chen Y; Zheng Y; Yang F
    Int J Gynecol Cancer; 2023 Dec; 33(12):1976-1977. PubMed ID: 37597853
    [No Abstract]   [Full Text] [Related]  

  • 4. Cardiophrenic lymph node resection in cytoreduction for primary advanced or recurrent epithelial ovarian carcinoma: a cohort study.
    Lopes A; Rangel Costa RL; di Paula R; Anton C; Calheiros Y; Sartorelli V; Kanashiro YM; de Lima JA; Yamada A; Pinto GLS; Vianna MR; Nogueira Dias Genta ML; Ribeiro U; Dos Santos MO
    Int J Gynecol Cancer; 2019 Jan; 29(1):188-194. PubMed ID: 30640703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.
    Angeles MA; Ferron G; Cabarrou B; Balague G; Martínez-Gómez C; Gladieff L; Pomel C; Martinez A
    Eur J Surg Oncol; 2019 Aug; 45(8):1410-1416. PubMed ID: 30857876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transdiaphragmatic cardiophrenic lymph node resection in a patient with an advanced-stage ovarian cancer.
    Turkmen O; Kilic F; Ersak B; Kimyon Comert G; Ayhan S; Ozdemir M; Turan T
    J Obstet Gynaecol; 2022 Apr; 42(3):527-529. PubMed ID: 34379542
    [No Abstract]   [Full Text] [Related]  

  • 7. Transdiaphragmatic and transxiphoid cardiophrenic lymph node resection step-by-step in advanced ovarian cancer.
    Martínez-Gómez C; Angeles MA; Leray H; Tanguy Le Gac Y; Ferron G; Martinez A
    Int J Gynecol Cancer; 2020 Oct; 30(10):1646-1647. PubMed ID: 32958542
    [No Abstract]   [Full Text] [Related]  

  • 8. Surgical management of cardiophrenic lymph nodes in patients with advanced ovarian cancer.
    Prader S; Harter P; Grimm C; Traut A; Waltering KU; Alesina PF; Heikaus S; Ataseven B; Heitz F; Schneider S; du Bois A
    Gynecol Oncol; 2016 May; 141(2):271-275. PubMed ID: 26972337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recurrence patterns in patients with abnormal cardiophrenic lymph nodes at ovarian cancer diagnosis.
    Larish A; Mert I; McGree M; Weaver A; Sheedy S; Cilby W
    Int J Gynecol Cancer; 2020 Apr; 30(4):504-508. PubMed ID: 31953350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility, safety and clinical outcomes of cardiophrenic lymph node resection in advanced ovarian cancer.
    Cowan RA; Tseng J; Murthy V; Srivastava R; Long Roche KC; Zivanovic O; Gardner GJ; Chi DS; Park BJ; Sonoda Y
    Gynecol Oncol; 2017 Nov; 147(2):262-266. PubMed ID: 28888540
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic value of selective lymphadenectomy in interval debulking surgery for stage IIIc and IV epithelial ovarian cancer.
    Song N; Gao Y
    Int J Gynecol Cancer; 2019 May; 29(4):761-767. PubMed ID: 30850437
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What can we learn from the 10 mm lymph node size cut-off on the CT in advanced ovarian cancer at the time of interval debulking surgery?
    Benoit L; Zerbib J; Koual M; Nguyen-Xuan HT; Delanoy N; Le Frère-Belda MA; Bentivegna E; Bats AS; Fournier L; Azaïs H
    Gynecol Oncol; 2021 Sep; 162(3):667-673. PubMed ID: 34217542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer.
    LaFargue CJ; Bristow RE
    Gynecol Oncol; 2015 Sep; 138(3):762-3. PubMed ID: 26049122
    [No Abstract]   [Full Text] [Related]  

  • 14. Salvage lymphadenectomy in recurrent ovarian cancer patients: Analysis of clinical outcome and BRCA1/2 gene mutational status.
    Gallotta V; Bruno M; Conte C; Giudice MT; Davià F; Moro F; Zannoni GF; Fagotti A; De Bonis M; Capoluongo E; Scambia G; Ferrandina G
    Eur J Surg Oncol; 2020 Jul; 46(7):1327-1333. PubMed ID: 32085925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metastasis to para-aortic lymph nodes cephalad to the renal veins in patients with ovarian cancer.
    Komiyama S; Nagashima M; Taniguchi T; Rikitake T; Morita M
    World J Surg Oncol; 2020 Apr; 18(1):64. PubMed ID: 32238145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there any therapeutic role of pelvic and para-aortic lymphadenectomy in apparent early stage epithelial ovarian cancer?
    Bizzarri N; du Bois A; Fruscio R; De Felice F; De Iaco P; Casarin J; Vizza E; Chiantera V; Corrado G; Cianci S; Magni S; Ferrari D; Giuliani D; Harter P; Ataseven B; Bommert M; Perrone AM; Scambia G; Fagotti A
    Gynecol Oncol; 2021 Jan; 160(1):56-63. PubMed ID: 33168305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of mesenteric lymph nodes involvement in patients undergoing posterior pelvic exenteration during radical or supra-radical surgery for advanced ovarian cancer.
    Berretta R; Capozzi VA; Sozzi G; Volpi L; Ceni V; Melpignano M; Giordano G; Marchesi F; Monica M; Di Serio M; Riccò M; Ceccaroni M
    Arch Gynecol Obstet; 2018 Apr; 297(4):997-1004. PubMed ID: 29380107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Factors Affecting Lymph Node Metastasis in Clinical Stage I-II Epithelial Ovarian Cancer.
    Erdem B; Yüksel IT; Peker N; Ulukent SC; Aşıcıoğlu O; Özaydin IY; Ülker V; Akbayir O
    Oncol Res Treat; 2018; 41(7-8):444-448. PubMed ID: 29975960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Robotic pelvic and para-aortic retroperitoneal lymph nodes staging for early-stage epithelial ovarian cancer.
    Couet D; Tate B; Nguyen-Xuan HT; Koual M; Bats AS; Azais H; Bentivegna E
    Int J Gynecol Cancer; 2023 Jun; 33(6):997-998. PubMed ID: 36600532
    [No Abstract]   [Full Text] [Related]  

  • 20. What are the implications of radiologically abnormal cardiophrenic lymph nodes in advanced ovarian cancer? An analysis of tumour burden, surgical complexity, same-site recurrence and overall survival.
    Addley S; Asher V; Kirke R; Bali A; Abdul S; Phillips A
    Eur J Surg Oncol; 2022 Dec; 48(12):2531-2538. PubMed ID: 35718677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.